Photo not available

Tihomir Miralem, Ph.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 712
Rochester, NY 14642

Lab: (585) 275-0361
Office: (585) 275-3843
Fax: (585) 275-6007


The biographical information for Tihomir Miralem, Ph.D. is not currently available.

Recent Journal Articles

Showing the 5 most recent journal articles. 14 available »

2007 Mar 16
Maines MD, Miralem T, Lerner-Marmarosh N, Shen J, Gibbs PE. "Human biliverdin reductase, a previously unknown activator of protein kinase C betaII." The Journal of biological chemistry. 2007 Mar 16; 282(11):8110-22. Epub 2007 Jan 16.
2005 Apr 29
Miralem T, Hu Z, Torno MD, Lelli KM, Maines MD. "Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells." The Journal of biological chemistry. 2005 Apr 29; 280(17):17084-92. Epub 2005 Feb 28.
2004 May 7
Kravets A, Hu Z, Miralem T, Torno MD, Maines MD. "Biliverdin reductase, a novel regulator for induction of activating transcription factor-2 and heme oxygenase-1." The Journal of biological chemistry. 2004 May 7; 279(19):19916-23. Epub 2004 Feb 25.
2003 Jan
Miralem T, Avraham HK. "Extracellular matrix enhances heregulin-dependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus." Molecular and cellular biology. 2003 Jan; 23(2):579-93.
2001 Sep 6
Miralem T, Steinberg R, Price D, Avraham H. "VEGF(165) requires extracellular matrix components to induce mitogenic effects and migratory response in breast cancer cells." Oncogene. 2001 Sep 6; 20(39):5511-24.

Current Appointments

Research Assistant Professor (Part-Time) - Department of Biochemistry and Biophysics (SMD) - Primary


PhD | Biochemistry | Canada-U Toronto-Toronto1998
MS | Biochemistry, All Other | Yugoslavia-Med Fac Zagreb1982
BS | Pharmacy | Yugoslavia-Med Fac U Sarajevo1978